Abstract
Antigen-specific CD8+ T cells acquire peptide–major histocompatibility complex (MHC) clusters through T-cell receptor (TCR)–mediated endocytosis after specific antigen stimulation. We generated an antigen-presenting cell (APC) expressing human leukocyte antigen (HLA)-A*201 coupled to the enhanced green fluorescent protein (GFP), which delivered GFP to an antigen-specific T cell when pulsed with antigenic peptide. We quantitatively identified human T-cell lymphotropic virus type I (HTLV-I) Tax(11–19) peptide–specific T-cell populations in peripheral blood mononuclear cells (PBMCs) from patients with HTLV-I–associated neurologic disease and defined a new CD8+ T-cell epitope in the HTLV-I envelope region. Acquisition of peptide–HLA-GFP complexes by antigen-specific T cells could distinguish, with respect to phenotype and perforin production, T cells from the chronic viral infections cytomegalovirus and HTLV-I. This approach will be a powerful tool in understanding the role of antigen-specific T-cell responses in health and disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




References
Altman, J.D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94–96 (1996).
Huang, J.F. et al. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 286, 952–954 (1999).
Stinchcombe, J.C., Bossi, G., Booth, S. & Griffiths, G.M. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15, 751–761 (2001).
Gessain, A. et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407–410 (1985).
Osame, M. et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1, 1031–1032 (1986).
Jacobson, S., Shida, H., McFarlin, D.E., Fauci, A.S. & Koenig, S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348, 245–248 (1990).
Bangham, C.R. The immune response to HTLV-I. Curr. Opin. Immunol. 12, 397–402 (2000).
Yamano, Y. et al. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99, 88–94 (2002).
Jacobson, S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J. Infect. Dis. 186 (suppl. 2), S187–S192 (2002).
Frangione-Beebe, M. et al. Enhanced immunogenicity of a conformational epitope of human T- lymphotropic virus type 1 using a novel chimeric peptide. Vaccine 19, 1068–1081 (2000).
Mendez, E. et al. Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor α and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells. J. Virol. 71, 9143–9149 (1997).
Parker, K.C., Bednarek, M.A. & Coligan, J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152, 163–175 (1994).
Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106–111 (2001).
Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8, 379–385 (2002).
Hamann, D. et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186, 1407–1418 (1997).
Osame, M. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J. Neurovirol. 8, 359–364 (2002).
Nagai, M. et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J. Neurovirol. 4, 586–593 (1998).
Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708–712 (1999).
Winter, C.C., Carreno, B.M., Turner, R.V., Koenig, S. & Biddison, W.E. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens. J. Immunol. 146, 3508–3512 (1991).
Osame, M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. in Human Retrovirology HTLV (ed. Blattner, W.) 191–197 (Raven Press, New York, 1990).
Kubota, R., Soldan, S.S., Martin, R. & Jacobson, S. An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease. J. Immunol. 164, 5192–5198 (2000).
Acknowledgements
We thank K. Yao, S. Gagnon and S. Soldan for helpful comments, and R. Turner for help with flow cytometry. U.T. was supported by the Japanese Society for the Promotion of Science and a US National Institutes of Health Research Fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Tomaru, U., Yamano, Y., Nagai, M. et al. Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide–HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections. Nat Med 9, 469–475 (2003). https://doi.org/10.1038/nm845
Published:
Issue date:
DOI: https://doi.org/10.1038/nm845
This article is cited by
-
Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs
Journal of Molecular Medicine (2019)
-
Intercellular Exchange of Surface Molecules and its Physiological Relevance
Archivum Immunologiae et Therapiae Experimentalis (2010)
-
A simple trogocytosis-based method to detect, quantify, characterize and purify antigen-specific live lymphocytes by flow cytometry, via their capture of membrane fragments from antigen-presenting cells
Nature Protocols (2006)
-
Quantifying viable virus-specific T cells without a priori knowledge of fine epitope specificity
Nature Medicine (2006)
-
Understanding the response to immunotherapy in humans
Springer Seminars in Immunopathology (2005)